Precision for Medicine Acquires ACT Oncology         

The ACT Difference

ACT Oncology was strategically built to manage oncology trials.  Since our inception in 2000, ACT has maintained one focus - to deliver innovative, cost-efficient and quality solutions in oncology research.  Over the past 15 years, ACT has developed into a full-service oncology CRO, offering our clients the highest level of expertise and operational experience in managing some of the most complex oncology trials in the industry. 

Our focus and continuous dedication to oncology research didn't happen by chance.  Our growth has been organic and by design; we recruit, train and retain some of the most seasoned oncology experts in the industry.  ACT Oncology’s team of clinical research experts has an average of over 18 years of experience in specialized oncology drug development. Our team members are passionate about their roles in developing new cancer treatments. We collaborate closely with Sponsors to ensure the success of each partnership.

From strategic planning and project management, to execution and follow-up, ACT Oncology’s dedicated team is focused on proactively addressing the unique needs of each program. Strategic use of study-specific Study Quality Metrics ensures that our Sponsors are able to tightly monitor progress toward meeting project goals, timelines and budgets.

Experience and Expertise

ACT Oncology offers our Sponsors valuable experience in a wide range of oncology indications, both hematologic and solid tumor types. Since 2000, we have managed over 300 projects.  Some highlights of our experience include:

  • Global programs with centralized leadership and regional teams
  • Complex rescue studies, transitioned from other large and niche oncology CROs
  • Numerous, complex Phase I-II/Proof of Concept studies
  • Over 30 multiple myeloma studies
ACT_Oncology_Phase_Chart_20151202-01

The majority of ACT Oncology's experience has been in Phase I-II/Proof-of-Concept studies, but we continue to expertly support Sponsors' needs in every phase of the development life cycle.

ACT_Oncology_Indication_Chart_20151202-01

ACT Oncology has vast experience in most hematology and oncology indications.

We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at precisionforoncology.com to see how we’re delivering the next generation of CRO services for oncology innovators.